Article info
PDFGenetics
Newborn screening: new developments, new dilemmas
- Correspondence to: Dr N J Kerruish Department of Paediatrics and Child Health, Dunedin School of Medicine, University of Otago, PO Box 913, Dunedin, New Zealand; nikki.kerruishstonebow.otago.ac.nz
Citation
Newborn screening: new developments, new dilemmas
Publication history
- Received February 2, 2004
- Accepted August 2, 2004
- Revised June 7, 2004
- First published June 30, 2005.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes
- Primary prevention of neurological illness early in life
- Economic evaluation of newborn deafness gene screening as a public health intervention in China: a modelling study
- What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
- Ethical issues in predictive genetic testing: a public health perspective
- Two faces of patient advocacy: the current controversy in newborn screening
- The new genetics: Genetic testing and public policy
- Effective screening leads to better outcomes in sickle cell disease
- Commercial predictive testing: the desirability of one overseeing body
- Newborn and childhood screening programmes: criteria, evidence, and current policy